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Abstract
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While large epidemiological datasets can inform research on the etiology and development of
borderline personality disorder (BPD), they rarely include BPD measures. In some cases, however,
proxy measures can be constructed using instruments already in these datasets. In this study we
developed and validated a self-report measure of BPD from the Multidimensional Personality
Questionnaire (MPQ). Items for the new instrument—the Minnesota BPD scale (MBPD)—were
identified and refined using three large samples: undergraduates, community adolescent twins, and
urban substance users. We determined the construct validity of the MBPD by examining its
association with (1) diagnosed BPD, (2) questionnaire reported BPD symptoms, and (3) clinical
variables associated with BPD: suicidality, trauma, disinhibition, internalizing distress, and
substance use. We also tested the MBPD in two prison inmate samples. Across samples, the
MBPD correlated with BPD indices and external criteria, and showed incremental validity above
measures of negative affect, thus supporting its construct validity as a measure of BPD.
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Borderline Personality Disorder; Scale Development; Multidimensional Personality;
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Borderline personality disorder (BPD) is a severe and persistent form of psychopathology
characterized by pervasive affective, cognitive, interpersonal, and behavioral dysfunction,
including emotional lability, interpersonal disturbances, impulsive and risky behaviors, and
transient episodes of dissociation or paranoia (APA, 1994; Linehan et al., 1993; Gunderson,
2001, Skodol, 2002). Individuals with BPD often engage in dangerous behavior, including
deliberate self-harm and suicidal gestures, drug and alcohol abuse, unsafe sexual practices,
and misuse of prescription medications (APA, 1994; Gunderson, 2001; Frankenburg &
Zanarini, 2004; Links et al., 1995; Skodol et al., 2002, 2005; Trull et al., 2000; Zanarini et
al., 1998a). Such individuals have poor longitudinal outcomes, including low life
satisfaction, academic and occupational difficulties, and elevated mental health service
utilization (Winograd, Cohen, & Chen, 2008).
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Traditionally, BPD research has been conducted in clinical samples consisting mainly of
Caucasian, female, upper-middle class, psychiatric inpatients hospitalized for recent suicide
attempts (e.g., Silk, Lee, Hill, & Lohr, 1995; Zanarini et al, 2002; Zanarini, Frankenburg,
Khera, & Bleichmar, 2001). Research on psychiatric samples has provided valuable
information about the correlates and comorbidity of BPD. Yet, there is a great deal about the
etiology of BPD that cannot be understood from the study of clinic-based samples alone. For
instance, much remains unknown about the epidemiology, genetics, onset, and course of
BPD. Answering such questions requires the statistical power and methodology provided by
large, representative samples that are followed longitudinally.
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Longitudinal datasets such as the Dunedin Multidisciplinary Health and Development Study
(Langley, Moffitt, & Silva, 1997; the Iowa development projects (Iowa Family Transitions
Project, Iowa Youth and Families Project, Iowa Single Parent Project; Donnellan, Assad,
Robins & Conger, 2007; Donnellan, Conger, & Burzette, 2007; Ge & Conger, 1999; Kim,
Conger, Lorenz, & Elder, 2001); the Minnesota Study of Twins Reared Apart (Bouchard,
Lykken, McGue, Segal, & Tellegen, 1990) and the Minnesota Twin and Family Study
(Iacono et al, 1999) (to name some of the more known ones) contain a wealth of
developmental, genetic, and psychophysiological information critical to understanding
personality and psychopathology. Unfortunately, these large datasets lack direct assessment
of BPD. However, if BPD can be measured using inventories of normal personality that are
routinely administered in such large-scale investigations, however, the data collected could
be used to answer questions about the disorder that are difficult or impossible to test in
smaller, clinically ascertained cross-sectional samples. Such investigations can then inform
more targeted projects that are specifically designed for BPD research.
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This approach has been successfully utilized in previous research. Indeed, multiple studies
have shown that BPD can be mapped from several continuous personality measures such as
the Five Factor Model (FFM; Costa & McCrae, 1992; Saulsman, & Page, 2004; Clarkin,
Hull, Cantor, & Sanderson, 1993), the Temperament and Character Inventory (Cloninger,
Svrakic, & Przybeck, 1993; Ball, Tennen, Poling, Kranzler, & Rounsaville, 1997), and the
Schedule for the Nonadaptive and Adaptive Personality (SNAP; Clark, 1993; Reynolds &
Clark, 2001). For example, Trull and colleagues (2003) have utilized the NEO-Personality
Inventory Revised (NEO-PI-R), a measure of the Five-factor model (FFM) of personality, to
develop a new measure of BPD based on the congruence between NEO-PI–R scores and an
expert rating profile of prototypical BPD traits. Similarly, Miller and colleagues (2001)
utilized the NEO-PI-R to develop a measure of psychopathy. The BPD and psychopathy
profiles were subsequently validated against several external correlates, including childhood
trauma, parental psychopathology, and poor social functioning. Such results provide
confidence that inventories of normal personality can be used to index personality disorders
in general and BPD in particular.
A key consideration in developing a novel measurement of psychopathology are the existing
instruments available for validation purposes. Fortunately, there are several well-established
measures of borderline personality symptoms. These include the Personality Assessment
Inventory – Borderline Subscale (PAI-BOR, Morey, 1991), the Personality Disorder
Questionnaire-4 (Hyler, 1994), the Borderline Symptom List (Bohus et al., 2001), and the
Zanarini Rating Scale For Borderline Personality Disorder (Zanarini et al, 2003). The PAIBOR is one of the more widely-used measures and has demonstrated excellent psychometric
properties in prior published work, including strong convergence with diagnostic measures
of BPD (Trull, 1995). Moreover, Trull et al (2003) found that the PAI-BOR demonstrated
high correlations with the FFM BPD prototype profile. Additionally, several recent studies
indicate that self-report questionnaires are practical and valid alternatives to interview-based
approaches (Hopwood et al., 2008; Jacobo, Blais, Baity, & Harley, 2007; Stein, Pinkster-
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Aspen, & Hilsenroth, 2007). Also, recent data indicate that the effectiveness of interview
and self-report varies depending on the symptom being assessed. For example, Hopwood
and colleagues (2008) reported that self-report instruments show higher validity when
measuring experiential symptoms (i.e., identity disturbance and chronic emptiness) whereas
interview-based methods showed higher validity in relation to observable and behavioral
symptoms such as deliberate self-harm and impulsive acts.
Overview of Current Investigation
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Inspired by the success of previous efforts to index personality syndromes using normal
personality measures (Trull et al, 2003; Benning et al, 2005a,b; Miller et al., 2001), the
current investigation utilized the Multidimensional Personality Questionnaire (MPQ,
Tellegen, 1982, 1988, Patrick et al., 2002), a broadband inventory of normal-range
personality traits. As such, our goal was to derive an index of BPD from a personality
inventory that is commonly administered in epidemiological data sets. In other words, our
goal was not to create a new measure of BPD symptoms and traits (a process in which new
items would be generated and refined through multiple rounds of data collection). Rather,
we aimed to develop a valid measure of BPD tendencies from the MPQ, an existing
omnibus personality inventory, now available in the popular brief form (Patrick et al., 2002),
that has been in wide-ranging use for several decades in key studies (e.g., Ben-Porath et al,
1995; Bouchard, et al, 1990; Caspi et al, 1997; Church, & Burke, 1994; Donnellan, et al,
2007; Markon, et al, 2005; Donnellan, et al, 2007; Ge & Conger, 1999; Kim, et al, 2001). To
develop and validate the MPQ-derived BPD scale, we capitalized on two community and
two clinical datasets. In the first study, we identified candidate items for the novel measure
in a) a large sample of mixed-gender undergraduate students using the PAI-BOR scale as the
criterion, and b) a sample of mixed-gender urban substance users using a diagnosis of BPD
as the criterion. After identifying this pool of candidate items, we selected the final set of
items using an epidemiological sample of adult youth recruited from the community. Next,
we tested the association between our new scale—the Minnesota Borderline Personality
Disorder Scale (MBPD)—and external correlates empirically associated with BPD, such as
childhood trauma, behavioral disinhibition, and substance use. (See Figure 1 for a graphical
depiction of these validation procedures.)
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In study 2, we explored the utility of the MBPD scale in two samples of male and female
prison inmates. In this study, we examined associations of the MBPD with several external
measures and scale scores from a number of normal personality inventories. The use of
urban substance users and prison inmates capitalizes on the expectation that they may be
especially vulnerable to the development of BPD, given their heightened risk for many of
the hypothesized risk factors for BPD, including BPD-relevant personality traits (e.g.,
impulsivity; Casillas & Clark, 2002; Moeller et al., 2002; Patton et al, 1995), environmental
adversity (e.g., abuse, neglect, disruptions in attachment, and exposure to violence; see
Fleming et al., 1998; Jasinski et al., 2000; Schwartz et al., 2005, Romero-Daza et al., 2003,
Verona, Hicks, & Patrick, 2005), and behaviors associated with BPD itself including
deliberate self-harm and suicidal behavior (Verona et al, 2001; Verona et al, 2005; Fulwiler,
Forbes, Santangelo, & Folstein, 1997; Evren, Sar, Evren, & Dalbudak, 2008; Cottler,
Campbell, Krishna, Cunningham-Williams, & Abdallah, 2005). Earlier studies suggest
elevated rates of BPD among both drug users and prison inmates (Jordan, Schlenger,
Fairbank, & Caddell, 1996; Zlotnick, 1997; Hochhausen, Lorenz, & Newman, 2002).
Together, these findings support the utility of research with drug users and prison inmates
for evaluating the performance of a novel BPD measure.
Scale construction and validation requires stipulating the expected correlates of BPD and
then evaluating the extent to which a new measure exhibits predicted patterns of association
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with these external criteria. Behavioral disinhibition (Siever & Davis, 1991; Skodol et al.,
2002) and affective dysregulation (Siever & Davis, 1991; Siever, Torgersen, Gunderson,
Livesley, & Kendler, 2002; Skodol et al., 2002; Linehan, 1993; Livesley, Jackson, &
Schroeder, 1992; Livesley, Jang, & Vernon, 1988) are considered to be two core
temperamental liabilities for the development of BPD with clear links to models of normalrange personality (Trull et al, 2003; Costa & McCrae, 1990). BPD is also associated with a
history of childhood trauma, adult victimization, and subsequent posttraumatic stress
disorder (Zanarini et al, 1997, 2000; Linehan, 1993). Finally, individuals with BPD exhibit
substantial psychiatric comorbidity, with elevated rates of mood and anxiety disorders
(Zanarini et al, 1997; Zanarini et al, 1998a), substance use disorders (Zanarini et al, 1998a),
and antisocial behavior (Paris, 1997).
Relying on previous research, we formulated four hypotheses for the current study. We
predicted that MBPD scores would be associated with (1) childhood abuse and symptoms of
PTSD; (2) disinhibitory behaviors, including impulsivity, criminal and antisocial behavior,
substance use, and suicidal behavior; (3) indices of internalized distress such as depression,
anxiety, and fear; and (4) personality traits such as neuroticism and stress reaction. Given
that some (albeit somewhat inconsistent) evidence suggests gender differences in both the
rates and clinical presentation of BPD (Paris, 1997), we examined our predictions separately
for male and female samples.
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STUDY 1. CREATING AN MPQ ITEM-BASED SCALE
Method
As noted above, Study 1 included three separate samples evaluated with different sets of
instruments and procedures. All participants provided written consent after written and oral
assurances of confidentiality. The current study was approved by the University of
Minnesota Institutional Review Board.
Sample 1:Undergraduate Students
Participants: Participants were 288 (57% female) students recruited from the “Introduction
to Psychology” subject pool. The mean age for the sample was 20.5 years (SD = 2.9 years).
Eighty-six percent of the participants were non-Hispanic White.
Study questionnaires were administered and monitored by research assistants in classrooms
and auditoriums. Participants were compensated with extra class credit or a $10 payment.
Items from the target measures (see below) were randomly included with items from other
questionnaires to offset order effects.

NIH-PA Author Manuscript

Measures: To document and ensure reliability, across the many measures used in the
current report, we examined four reliability indices. Diagnostic reliability was calculated
from the kappa coefficient, scale internal consistency was evaluated using Cronbach’s α, and
the reliability of a composite measure composed of multiple scales was determined by
examining mean inter-scale correlations Finally, mean inter-item correlations were used to
index correlations among categorical items (e.g., experience of some type of negative life
event such as rape) composing a scale.
MPQ-Brief Form (MPQ-BF; Patrick et al., 2002): The MPQ is a self-report personality
inventory that was developed through factor analysis to assess normal personality
functioning. The MPQ-BF is a 155-item version of the original 300-item MPQ (Tellegen,
1982), developed to assess a variety of personality traits and temperamental dispositions.
Items have a dichotomous, “true” or “false” response format. MFQ-BF includes 11 primary
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trait scales which load onto three higher-order factors. The traits of Well-Being,
Achievement, Social Closeness, and Social Potency load onto the higher-order factor of
Positive Emotionality (predisposition to experiencing positive affect); the traits of Stress
Reactivity, Alienation, and Aggression make up the higher-order factor of Negative
Emotionality (the predisposition to experiencing negative affect); the traits of Control, Harm
Avoidance, and Traditionalism load on the higher-order factor of Constraint (predisposition
to behavioral self-control, the converse of disinhibition); and the trait of Absorption does not
load preferentially on any of the higher-order factors. Scores from the traits scales of the
MPQ-BF are highly correlated with the equivalent trait scales from the original MPQ (r’s
ranged from .92 to .96) and have demonstrated high internal consistency (α’s range from .74
to .84; Patrick et al., 2002).
PAI-BOR (Morey, 1991): BPD features were assessed by self-report using the PAI-BOR.
The PAI-BOR consists of 24 items rated on a 4-point scale ranging from 1 (false) to 4 (very
true). The measure has four subscales: Affective Instability, Identity Problems, Negative
Relationships, and Self-Harm (Morey, 1991). The PAI-BOR exhibits good internal
consistency (α = .84; Morey, 1991), high test-retest reliability over a 3- to 4-week time
period (r = .86; Morey, 1991), and good convergent and discriminant validity (Stein,
Pinsker-Aspen, & Hilsenroth, 2007; Trull, 1995). Item and scale loadings are similar across
age and gender (DeMoor et al, 2009). Cronbach’s α in the current sample was .85.

NIH-PA Author Manuscript

Sample 2: Urban Drug Users
Participants: We enrolled 146 inpatient residents in a drug and alcohol abuse treatment
center in Northeast Washington, D. C. Treatment residency ranges from 30 to 180 days.
Program admission required complete abstinence from alcohol and drugs (including
methadone) except for caffeine and nicotine. Regular drug testing was mandated and
substance use was grounds for dismissal. If needed, detoxification took place prior to
program admission. Aside from authorized outside activities (e.g., group retreats, physician
visits), residents could not leave the center grounds during treatment.
Study participants ranged in age from 18 to 67 years, with a mean age of 42.0 years (SD =
9.2 years). Sixty-five percent were male; 92% self-identified as African-American, 6.3% as
non-Hispanic white, 0.6% as Hispanic, and 1.1% as other. Among the sample, 21.1% had
not completed high school or earned a GED, 42.9% had completed high school or received a
GED, and 36.1% had enrolled in college or a technical school. Most participants were single
(69.0%) and unemployed (68.0%). Residents were asked to participate in the study within
one week of arriving at the treatment center.

NIH-PA Author Manuscript

Measures: In addition to the MPQ-BF, all participants completed a battery of self-report
questionnaires to determine associations between the MBPD scales and external correlates.
Structure interviews and measures were randomly sequenced across participants to limit
order effects. The instruments are discussed below within each domain of interest.
Assessment of BPD: We used the Structured Clinical Interview for DSM-IV Axis II
Disorders (SCID-II) to determine BPD diagnostic status (First et al., 1997). Interviews were
conducted by Dr. Bornovalova, who was trained in administration of the SCID-II. These
interviews were conducted with no knowledge of participant scores on others study
measures. Twenty-five percent of these interviews were reviewed by another PhD-level
clinician. In the three cases where a discrepancy existed, a consensus was reached. Based on
SCID-II results, 37% of the women (n = 19) and 11% of the men (n = 10) had diagnosis of
BPD. Participants also completed the self-report Inventory for Interpersonal Problems-BPD
scale (IIP-BPD) which uses two of the five IIP scales: interpersonal sensitivity and
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aggression (Lejuez et al, 2003; Pilkonis, Kim, Proietti, & Barkham, 1996). These subscales,
theoretically and empirically associated with BPD, are related to central features of the
disorder in non-clinical samples of college students and of substance users (Lejuez et al.,
2003). Cronbach’s α for the IIP-BPD in the current sample was .91.
Substance dependence: The Structured Clinical Interview for DSM-IV Axis I Disorders
(SCID; First et al., 1996) was used to assess dependence on alcohol, cannabis, crack/
cocaine, heroin, and hallucinogens. (Administration protocol mirrored the SCID-II above.)
We also administered a self-report measure assessing past year use of alcohol, marijuana,
crack/cocaine, heroin, and PCP.

NIH-PA Author Manuscript

Antisocial behavior/behavioral disinhibition: Because previous studies indicated that BPD
was correlated with behavioral problems and antisocial behavior (Frankenburg & Zanarini,
2004; Dougherty et al, 1999), we assessed conduct disorder (CD; childhood criteria for
antisocial personality disorder) and antisocial personality disorder. Additionally, we
administered two scales measuring trait-impulsivity, the UPPS Impulsive Behavior Scale
(UPPS; Whiteside & Lynam, 2001), and the Barratt Impulsiveness Scale Version 10
(BIS-10; Barratt & Patton, 1983, Barratt, 1985). The UPPS is a 45-item self-report measure
used to measure four impulsivity-related traits: Urgency, (lack of) Premeditation, (lack of)
Perseverance, and Sensation Seeking. In the current study, all but the Sensation Seeking
scale were administered to the sample of drug users (α = .88). The BIS-10 is a 34-item
measure of impulsivity that also demonstrated excellent psychometric properties with this
sample (α = .83). For the purposes of data reduction, we conducted a principal components
analysis on the six utilized subscales from both measures. This analysis produced a onefactor solution, accounting for 59% of the variance in the construct. This factor (termed
Impulsivity) was used as a criterion variable.
Internalizing distress: To assess internalizing distress, participants completed the Center for
Epidemiological Studies – Depression Scale (CES-D; Radloff, 1977). This 22-item selfreport scale is designed to measure affective components of depressive symptoms, including
depressed mood, feelings of guilt and worthlessness, psychomotor retardation, feelings of
helplessness and hopelessness, loss of appetite, and sleep disturbance during the past two
weeks (sample α = .84).
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Childhood trauma: Childhood abuse was assessed using the emotional, physical, and sexual
abuse subscales of the Childhood Trauma Questionnaire-Short Form (CTQ-SF; Bernstein et
al., 2003). The CTQ-SF is a 28-item measure that retrospectively assesses childhood
maltreatment. Previous studies indicated excellent psychometric properties for this scale
(Bernstein, Ahluvalia, Pogge, & Handelsman, 1997) which were also borne out for the
current sample (α = .86).
Sample 3: Adult Youth Twins Recruited from the Community
Participants: The sample included 510 male and 622 female twins drawn from the
Minnesota Twin Family Study (MTFS), a longitudinal investigation of the epidemiology of
psychiatric and substance abuse disorders. Twins born in Minnesota between1972 to 1979
(according to public records) were recruited into this study the year the twins turned 17
years old. Participants were drawn from the general community subject to two exclusionary
criteria. First, the families had to live within a day’s drive of the University of Minnesota
laboratories. Second, neither twin could have a physical or mental handicap that would
preclude participation in the day-long assessment (a full description of the design of the
MTFS has been provided elsewhere; Iacono et al., 1999). The mean age for the sample was
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The MTFS sample does not contain a diagnostic assessment of BPD, and thus, the rates of
BPD in the sample cannot be estimated. However, participants in this sample receive a
number of other diagnostic assessments for disorders that are known to be comorbid with a
diagnosis of BPD. In particular, at age 17, the rates of lifetime adult antisocial behavior
(AAB, adult criteria for antisocial personality disorder; 3.4% in men, 2.1% in women)
alcohol dependence (9.7% in men, 6.7% in women), illicit drug dependence (3.8% in men,
3.5% in women), and major depressive disorder (12.1% in men, 23.0% in women) are
similar to estimates from other large-scale studies (Grant et al, 2008). Given the high
comorbidity of BPD with these disorders, it is likely that BPD is present at rates commonly
found in epidemiological studies of young adults. All twins provided written informed
consent or assent as appropriate (parents provided informed consent for twins under age 18).
Measures: Participants in the Minnesota Twin Family Study completed a 198-item version
of the MPQ. The twins also completed several questionnaires and structured interviews to
test construct validity of MBPD scores within several domains.
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Substance Use and Abuse: Participants were interviewed for lifetime nicotine, alcohol, and
illicit drug abuse and dependence, as defined by the Diagnostic and Statistical Manual of
Mental Disorders (3rd ed Revised; DSM–III-R; American Psychiatric Association, 1987).
Researchers used the Substance Abuse Module (SAM) of the Composite International
Diagnostic Interview (Robins, Baber, Cottler, 1987). Kappa reliabilities were > .91 for each
substance use disorder diagnosis. The nicotine use/dependence variable was calculated by
taking the mean z-score of nicotine dependence symptoms, average number of days the
participant used tobacco in a month (0 to 30), and the average number of cigarettes (or other
tobacco products) used in a day. The alcohol use/dependence variable was calculated by
taking the mean z-score of alcohol abuse and dependence symptoms, number of lifetime
intoxications, and maximum number of drinks consumed in 24 hours. The drug use/
dependence variable was calculated by taking the mean z-score of drug abuse and
dependence symptoms, number of different illicit drug classes used, and number of lifetime
marijuana and stimulant uses. The mean inter-scale correlations for the nicotine, alcohol,
and drug-use composites were .76, .70, and .69, respectively.
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Antisocial behavior/behavioral disinhibition: Conduct disorder (CD) and adult antisocial
behavior (AAB) symptoms were assessed using a structured interview based on the
Structured Clinical Interview for DSM-III-R-II. Kappa reliabilities for diagnoses of CD and
AAB were .81 and .95, respectively. Non-diagnostic indicators of behavioral disinhibition
were obtained from the Life Events Interview (Billing et al., 1996). A scale score was
derived from these behaviors: history of suspension or expulsion from school; legal
difficulties other than traffic violations; and sexual intercourse before the age of 17.
Participants also completed the Delinquent Behavior Inventory, a 36-item (α = .95)
inventory of antisocial acts committed during adolescence (DBI, Gibson, 1967). Participants
also completed the Behavioral Disinhibition (BD) scale (Taylor et al., 2000), a 12-item (α
= .68) subscale of the California Psychological Inventory-Socialization scale (Gough, 1957,
1960). Finally, multiple teacher ratings were obtained for most participants (76%) using for
a 30-item (α = .92) scale of externalizing behavior. The teacher rating scale incorporates
DSM-III-R criteria for conduct disorder and oppositional defiant disorder, as well as trait
descriptors associated with externalizing behavior (e.g., impulsivity and aggressive).
A composite measure of antisocial behavior/behavioral disinhibition was calculated by
taking the mean z-score for (1) symptoms of CD and AAB, (2) Life Events Interview
Assessment. Author manuscript; available in PMC 2012 June 1.
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behavioral disinhibition items, (3) DBI scores, (4) BD scale scores, and (5) teacher ratings of
externalizing behavior (mean inter-scale correlation for composite = .43). An overall
Externalizing (EXT) composite variable was then calculated by using the mean z-score of
the composite antisocial behavior/behavioral disinhibition variable and the three substance
use/dependence variables (mean inter-scale correlation = .60).
Internalizing distress: Modules from the Structured Clinical Interview for DSM-III-R were
used to assess select mood and anxiety disorders. Specifically, participants were interviewed
for lifetime incidence of major depressive disorder, social phobia, and simple phobia. Kappa
reliabilities ranged from .78 to .89 for these disorders. Teacher ratings of students were
obtained on a 12-item (α = .85) rating scale measuring overall internalizing distress. The
INT variable was calculated by taking the mean z-score of the symptoms of the 3 disorders
and the teacher rating of internalizing distress.
Analytic Approach and Results for Initial Development of the Minnesota Borderline
Personality Disorder Scale (MBPD)
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We conducted the initial development and item selection of the MBPD in the three samples
described above. The initial items for the scale were selected using the undergraduate and
the urban drug user samples as each included a measure designed to assess BPD traits or
symptoms. The MTFS sample was then used to advantage for further refining and finalizing
our item selection. By reserving the MTFS sample for the final step in scale refinement, we
were able to reduce the number of items to a core set (Appendix A) the construct validity of
which was supported by the work carried out below.
Testing the Structural Relationship of MPQ Subscales with Measures of BPD
(Undergraduate and Urban Drug User Samples)—First, to determine if the MPQ
shows the same structural relationship to the two measures of BPD available in the
undergraduate and urban drug user samples, the PAI-BOR and BPD diagnostic symptom
counts were regressed onto the 11 primary MPQ scales. Table 1 provides the bivariate
correlations and beta weights of the MPQ primary scales with PAI-BOR scores and BPD
diagnostic symptom counts. Both the PAI-BOR scores and symptom counts were strongly
associated with Stress Reaction and moderately associated with Alienation, low Control,
Aggression, and low Well-being scores (gender differences and contrast zs for the MPQ
scales are also presented in Table 1). The multiple Rs were .85 and .71 (undergraduates and
urban drug users, respectively), which are similar tothe reliability of the PAI-BOR total
score. The fact that the MPQ has a similar structural relationship with two different BPD
measures and in the two different samples attests to the potential of a scale derived from
MPQ items to serve as a valid estimate of BPD tendencies.
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Identifying a Pool of Candidate Items for the MBPD Scale (Undergraduate and
Urban Drug User Samples)—As described above, the undergraduate sample contains
the PAI-BOR, and the urban drug user sample provides the diagnosis of BPD. To identify
candidate items, we took items from each sample that a) correlated greater than .2 with the
PAI-BOR and with the diagnosis of BPD, and b) overlapped across the two samples. We
identified 67 MPQ items in the undergraduate sample and 44 MPQ items in the substance
user sample. The items that overlapped between the two samples (36 items) were then
further examined using the MTFS sample. These items correlated well with the criterion
BPD measures (median value = .33; range = .20–.62).
Final Item Selection (MTFS Sample)—The final item selection took place in the MTFS
sample. First, because the MTFS sample lacks an explicit measure of BPD, the regression
weights derived from regressing the 11 MPQ subscales on PAI-BOR and BPD symptom
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count scores in the analyses above were used to provide anchor measures (termed PAI-BORest. and BPD symptoms-est.) for the MTFS sample. Next, we noted that many of the items
identified above focused on general distress or dysphoria (i.e., several items from the Stress
Reaction scale). To ensure that the MBPD scale would not simply be a measure of stress
reaction, we conducted a principal components analysis of the 36 items identified above.
Next, each item was individually entered into a regression equation with Stress Reaction,
predicting 1) PAI-BOR-est. and 2) BPD symptoms-est. Items were retained only if they
exhibited incremental predictive utility over scores on the Stress Reaction scale. This
refinement process generated 19 items with a Cronbach’s α = .83 (see Appendix for brief
item descriptions). The sum of these items correlated .90 with the PAI-BOR-est. and .86
with BPD symptoms-est.
Concurrent Validity—In the undergraduate sample, the correlation between scores on the
19-item MBPD scale and the PAI-BOR was .80, matching the internal consistency
reliability of the MBPD (α = .81). MBPD scores correlated moderately to strongly with all
PAI-BOR subscales, including Affective Instability (r = .73), Identity Problems (r = .64),
Negative Relationships (r = .51), and Self-Harm (r = .52). As such, the MBPD scale
appeared to provide adequate content coverage of the BPD construct.
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In the substance user sample, we examined associations between the MBPD (α = .78 for this
group) and SCID-II diagnoses of BPD, along with continuous scale measures of BPD
tendencies. Results are reported in Table 2. As BPD diagnosis is a categorical variable,
biserial correlations were calculated. For both male and female participants, there was a
strong association between MBPD scores and the BPD diagnosis. MBPD scores also
strongly correlated with IIP-BPD scores and multiple BPD symptoms on the SCID-II.
Mean Differences and External Correlates of the MBPD—Females scored
significantly higher than men on the MBPD among the substance user sample. The mean
(SD) was 8.24 (4.10) for males and 10.35 (3.84) for females (Cohen’s d = −.53, p < .01).
Table 2 includes correlations between MBPD scores and external criterion variables. For
both genders, MBPD scores were moderately to highly correlated with Conduct Disorder,
Adult Antisocial Behavior, and the Impulsivity composite. MBPD scores correlated to
substance use and substance dependence diagnoses in men only. There was a moderate
association with depression severity and childhood abuse for both men and women. While
women substance users exhibited slightly higher MBPD scores, there were no significant
gender differences in terms of correlations with external variables (see Table 2 for contrast z
statistics).
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In the MTFS sample, there were no gender differences in MBPD scores [mean (SD) = 43.60
(7.67) for males and 42.7 (8.76) for females (Cohen’s d = .11, p > .1). We also examined the
MBPD’s associations with theoretically relevant external criterion variables in the MTFS
sample. Table 3 lists the correlations between MBPD scores and composite measures of
substance use and abuse, behavioral disinhibition, and internalizing distress. For both men
and women, MBPD scores were positively and significantly (all ps < .001) correlated with
each composite variable including nicotine use/dependence, alcohol use/dependence, drug
use/dependence, antisocial behavior/behavioral disinhibition, EXT, and INT. We also
examined gender differences in mean-level MBPD scores and in the strength of the
correlations across all variables in the current large sample. Results indicated that there were
no significant gender differences in mean MBPD scores or in the magnitude of correlations
with external criterion variables (see Table 3 for contrast z statistics).
Incremental Validity of MBPD—Incremental validity was determined by testing whether
the MBPD accounted for variance in the criterion variables beyond negative affectivity as
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measured by the Negative Emotionality superfactor of the MPQ (Tellegen, 1982). We also
tested for gender differences. Specifically, we conducted a series of hierarchical regressions
with Negative Emotionality scores and gender entered in the first step and MBPD scores
entered in the second step with the external correlates of BPD (e.g., EXT, INT) as the
criterion. In the substance user sample, MBPD scores were incrementally predictive of
depression symptoms (R2Δ = .059, p < .001), impulsivity (R2Δ = .159, p < .001), and
number of substance dependence diagnoses (R2Δ = .027, p < .05). However, MBPD scores
did not predict childhood trauma (R2Δ = .004, p = .38), antisocial personality disorder status
(OR = 1.10, p = .29), or conduct disorder (OR = 1.07, p = .45) when controlling for
Negative Emotionality and gender. Finally, the MBPD scores were incrementally predictive
of BPD diagnostic symptom count (R2Δ = .039, p < .01), BPD diagnosis (OR = 1.29, p < .
05), and IIP-BPD scores (R2Δ = .049, p < .01).
In the community sample, the MBPD scores predicted nicotine use/dependence (Δ R2 = .
054, p < .001), alcohol use/dependence (Δ R2 = .051, p < .001), drug use/dependence (Δ R2
= .044, p < .05), and antisocial behavior/behavioral disinhibition (Δ R2 = .081, p < .001).
The new measure predicted EXT (Δ R2 = .081, p < .001) but not INT (Δ R2 = .001, p = .52).
(This result is not surprising, given that the conceptual constructs of INT and Negative
Emotionality strongly overlap). Taken together, these results support the construct validity
of MBPD scores.
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Mean Differences between Community and Clinical Samples—When examining
mean-level differences across sample populations, we expected the substance user group
would have higher MBPD scores than the community and undergraduate samples. Because
of slight response option differences across samples, we dichotomized the 4-point response
option for the MTFS sample to be on a similar scale as the other samples. With no
significant differences between the undergraduate and twin samples (p > .1), MBPD scores
were collapsed these into one sample. A 2 × 2 ANOVA – with sample group and gender
entered as independent variables, age as a covariate, and MBPD scores as the dependent
variable – revealed an effect of age [F(1, 1539) = 7.56; p < .01; lower age related to higher
BPD traits], sample [F(2, 1539) = 26.95; p <.01; undergraduate twin sample < drug user
sample], gender [F(1, 1539) = 8.38, p < .01; females > males], and sample X gender
interaction [F(1, 1539) = 9.35; p <.01]. The sample X gender interaction effect indicated that
females had higher levels of BPD traits than males in the drug user sample but not in the
combined undergraduate/twin sample. Each of these effects is consistent with the general
literature that also reports higher BPD traits in females compared to males, clinical
compared to community samples, and younger compared to older participants (Grant et al,
2008; Segal, Hook, & Coolidge, 2001; Widiger & Weissman, 1991). This provides
additional evidence that the MBPD is behaving in a way the larger BPD construct does.
Study 1 Discussion
Overall, the observed pattern of associations for MBPD scores is consistent with both
theoretical conceptualizations and the empirical literature, and provides an initial step in the
validation of the scale. The evidence also suggests that this measure is an index of
something beyond just negative affect – a finding that adds to its construct validity. Thus,
the initial validation results provide ground for cautious optimism about the validity of the
MBPD scale.
Next, we examined the validity of the MBPD scale in two samples characterized by elevated
levels of personality pathology: male and female prison inmates. As noted previously, a
number of studies have shown that prisoners demonstrate both an elevated rate of BPD
(Zlotnick, 1997; Hochhausen, Lorenz, & Newman, 2002) and behaviors associated with

Assessment. Author manuscript; available in PMC 2012 June 1.

Bornovalova et al.

Page 11

NIH-PA Author Manuscript

BPD such as substance use, violence, and deliberate self-injury (e.g., Verona et al, 2005). As
such, prison inmates are an excellent sample in which our novel scale can be validated. In
this study we examined the construct validity of the MBPD by delineating the associations
between MBPD scores and expected external correlates including childhood trauma,
behavioral disinhibition, substance use, and internalizing distress. As in Study 1,
associations with normal personality traits were also examined. Consistent with the
theoretical and empirical literature (Trull et al, 2003), we predicted that the MBPD scores
would be positively correlated with measures of behavioral disinhibition and negative
affectivity, and negatively correlated with measures of socialization and positive affect.

STUDY 2: PRISON INMATES: ASSOCIATION WITH PSYCHOPATHOLOGY
AND NORMAL PERSONALITY
Method
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Participants—The sample consisted of 240 male and 226 female inmates recruited from
two medium security federal prisons in Florida. Among the males, the racial/ethnic
composition was 47% non-Hispanic white, 40% African American, and 13% Hispanic.
Among females, the distribution was 57.1% African American, 29.6% non-Hispanic White,
10.6% Hispanic, and 2.6% other. For men, the mean age was 32.7 years old (SD = 7.8
years); for women, 31.9 years old (SD = 6.8). Participants were recruited randomly from a
master prison roster and contacted if they met inclusion criteria: a) absence of severe and
persistent mental illness; b) release date not imminent; c) conversational competency in
English, and d) ability to read the study description aloud. The study protocol received
approval by an internal review board. All participants provided written informed consent
prior to completing the structured interview and self-report questionnaires described below.
(See Table 4 for measures administered in the male and female inmates, which were treated
as separate samples). All participants also completed the MPQ. Cronbach’s α for the MBPD
in the males was .81 and in the females .82.
Male Prisoners
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Externalizing behavior: Antisocial behavior was assessed via structured interviews and a
review of the prison file. Interview items covered Conduct Disorder and Antisocial
personality disorder (adult criteria) as defined by Diagnostic and Statistical Manual of
Mental Disorders (4th ed.; DSM–IV; APA, 1994). All interviews, conducted by trained
research assistants, were videotaped and independently reviewed by two diagnosticians. The
diagnostic inter-rater reliability, assessed via the intraclass correlation (ICC), was .85 and .
91 for the adult and history of child symptoms, respectively. Measures of criminal behavior
included age of first criminal charge and number of charges before age 17. Based on records
and self-report, a criminal variety index detailed a prisoner’s engagement in different types
of crime. Finally, a violent behavior composite incorporated the number of child and adult
fights, history of domestic violence, and number of violent crimes (mean inter-item
correlation = .20).
Substance use and abuse: Alcohol and drug use were determined using self-report
questionnaires. The Survey of Alcohol and Drug Use (SADU) assessed quantity and
frequency of use for nicotine, alcohol, and seven drug classes (Bachman, Johnston, &
O’Malley, 1991). An overall substance use score was calculated utilizing the mean z-score
across the different substances (mean inter-item correlation = .25). Symptoms of alcohol
dependence, including severe miscues, were assessed using the 29-item Alcohol
Dependence Scale (ADS; Skinner & Allen, 1982; α = .91), emphasizing the more severe
manifestations of alcohol misuse. Additionally, the Drinking Motives Questionnaire (DMQ;
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Cooper, Russell, Skinner, & Windle, 1992) was administered to assess distinct alcohol use
patterns. A 15-item self-report measure, the DMQ includes three drinking motive scales:
Social (drink to socialize and interact with others) (α = .90), Coping (drink to cope with
emotional and other problems) (α = .89), and Enhancement (drinking to augment positive
feelings) (α = .89). Participants also completed the Short Drug Abuse Screening Test
(SDAST; Skinner, 1982), a 20-item questionnaire (α = .86) that assesses symptoms of drug
abuse and dependence.
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Internalizing distress: Inmates completed the Beck Depression Inventory (BDI; Beck et al.,
1961), a 21-item questionnaire (α = .86) that measures depression symptomology during the
last 2 weeks. Participants also completed the Penn State Worry Questionnaire (PSWQ;
Meyer, Miller, Metzger, & Borkovec, 1990), a 16-item scale (α = .88) assessing subjective
worry that correlates with other self-report anxiety measures (Hopko et al., 2003).
Additionally, inmates completed the muscular tension, autonomic arousal, and feelings of
anxiety scales of the Fenz-Epstein Questionnaire (FEQ; Fenz & Epstein, 1965) that provided
prison researchers with a total anxiety score (α = .86). Participants also completed the 52item Fear Survey Schedule III (FSS-III; Arrindell, Emmelkamp, & van der Ende, 1984),
which yields a total score (α = .94) and five subscale scores: social fears; agoraphobia; fears
of bodily injury, death, and illness; fears of sexual and aggressive scenes; and fears of
harmless animals. Finally, we determined if there was a history of suicide attempts from the
clinical interview and prison files.
Normal personality functioning: We examined associations between MBPD scores and
normal personality trait constructs via six well-validated self-report measures:
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1.

Neuroticism-Extraversion-Openness Five Factor Inventory (NEO-FFI). The 60item NEO-FFI (Costa & McCrae, 1992) assesses the “Big Five” model of normal
personality. This instrument provides scores on five trait constructs: Neuroticism (α
= .79), Extraversion (α = .63), Openness (α = .68), Agreeableness (α = .70), and
Conscientiousness (α = .82).

2.

Emotionality-Activity-Sociability-Impulsivity Temperament Survey (EASI). The 25item EASI was developed by Buss and Plomin (1975) to measure their model of
temperament traits. Emotionality (subscales Distress, Fearfulness, Anger; α = .80, .
55, .58, respectively) encompasses a person’s sensitivity and reaction to negative
emotions. Activity (α = .56) refers to the pace of a person’s life. Sociability (α = .
56) measures an individual’s fondness for personal interactions. Impulsivity (α = .
53) identifies a tendency to act before thinking.

3.

Positive and Negative Affect Schedule (PANAS)-Trait Version. This instrument
(Watson, Clark, & Tellegen, 1988) examines the frequency various mood states are
experienced. PANAS Positive Affect scores (α = .84) measure pleasurable states in
a person’s life, while PANAS Negative Affect scores (α = .84) quantify negativity.

4.

Anger Expression Questionnaire (AEQ). This 20-item inventory (α = .78;
Spielberger, 1988) assesses anger expression and regulation.

5.

Socialization (So) scale. This 54-item instrument is a subscale of the California
Psychological Inventory (α = .68; Gough, 1957, 1960). This measure of antisocial
tendencies sorts individuals in a stepwise fashion on a spectrum from model
citizens to incarcerated offenders.

6.

Sensation Seeking Scale (SSS). This 40-item measure (Zuckerman, 1979) examines
behavioral disinhibition and risk-taking tendencies. The SSS yields a total score
and four subscale scores: Disinhibition (α = .59), Boredom Susceptibility (α = .64),
Thrill and Adventure Seeking (α = .81), and Experience Seeking (α = .80).
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Measures Administered To Female Prisoners: The female inmates completed the very
similar self-report measures of substance use and abuse to that filled out by the male
inmates. All women received the self-report measures of substance use and abuse (SADU,
DMQ, ADS, and SDAST), and indices of antisocial, criminal, and violent behavior (CD,
AAB, criminality, violence composite) that were derived from the clinical interview and
from a review of prison file data available for each participant. The ICCs for AAB and CD
diagnoses were .85 and .91, respectively. History of suicide attempts (coded as present or
absent) was also assessed from the interview and review of the prison file (Verona et al.,
2005). The mean inter-item correlations for the violence composite and the SADU were
both .26. Cronbach’s alphas for the female sample were as follows: ADS (α = .93); DMQsocial (α = .88); DMQ-coping (α = .92); DMQ-enhancement (α = .94); SDAST (α = .93).
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Two additional instruments were also administered to assess trauma and symptoms of
posttraumatic stress disorder (PTSD). Lifetime exposure to traumatic events was assessed
using the Life Events Checklist (Gray et al., 2004). Given that traumatic events related to
abuse and assaults are most relevant to BPD, we computed an overall index of traumatic
events as the sum of all endorsed events on the checklist, as well as scores for subscales
reflecting only the abuse and assault items (i.e., childhood physical or sexual abuse, and
physical or sexual assault as an adult; mean inter-item correlation = .32). Symptoms of
PTSD were assessed using the civilian version of the PTSD Checklist (α = .92; Weathers et
al, 1993), a self-report questionnaire in which participants rated the extent to which each of
the 17 symptoms of PTSD was experienced during the past month. Finally, mental health
treatment history was collected from prisoner interviews and prison files. A composite
treatment measure was calculated by summing the presence (yes = 1, no = 0) of the
following indicators: treatment outside prison, treatment inside prison, history of psychiatric
hospitalization, and history of taking medications for anxiety (mean inter-item correlation
= .25).
Results for Male Prisoners: Table 4 lists the correlations between MBPD and the criterion
variables for all prisoners. For males, MBPD scores exhibited modest associations with CD,
AAB, and the violent behavior composite. MBPD scores also exhibited small to moderate
associations with scores on the SADU, ADS, SDAST, and the DMQ Coping scale. For
measures of internalizing distress, MBPD scores exhibited moderate to large associations
with scores on the BDI, PSWQ, FEQ, most FSS subscales, particularly the Social Fears and
Agoraphobia scales, and a history of suicide attempts.
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For normal personality traits, MBPD scores evidenced associations with scores on measures
of negative affect, including NEO-FFI Neuroticism; EASI Distress, Fearfulness, and Anger
subscales; PANAS Negative Affect; and the Anger Expression Questionnaire. MBPD scores
were negatively correlated with measures of positive affect, including PANAS Positive
Affect, NEO-FFI Extraversion, and EASI Sociability. There were small to moderate positive
correlations with indices of behavioral disinhibition, including EASI Impulsivity and SSS
Boredom Susceptibility and Disinhibition scales. Similarly, the MBPD was negatively
associated with measures of socialization, including NEO-FFI Agreeableness, NEO-FFI
Conscientiousness, and CPI Socialization. In sum, as expected, the MBPD correlated with
antisociality, alcohol and drug use, behavioral disinhibition, negative affect, suicidality, and
boredom susceptibility.
Results for Female Prisoners and Gender Differences
With regard to mean-level gender differences, females scored significantly higher than men.
For males the mean (SD) was 6.32 (4.04); for females it was 8.03 (4.24) (Cohen’s d = −.41,
p < .01). Table 4 lists the correlations between MBPD scores and criterion variables in the
female prisoner sample. In addition to results that generally parallel those obtained for the
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men for measures both samples had in common, MBPD scores exhibited moderate
associations with history of mental health treatment and trauma exposure (total trauma count
and assaults) as well as a strong association with symptoms of PTSD.
Finally, we examined gender differences in mean scores and the strength of the correlations
between MBPD scores and external criterion variables. There was a significant gender
difference in MBPD mean scores, with women scoring higher than men [F(1,454) = 19.31, p
< .001)]. As seen in Table 4, women also exhibited significantly higher correlations between
MBPD scores and Conduct Disorder symptoms, criminal charges before age 17, age of first
offense, and the DMQ Coping and Enhancement scales (all ps < .01) (see Table 4 for
contrast z statistics). There were trend level differences (in the same direction) for the
violent behavior composite and the DMQ Social scale (ps = .08 and .06, respectively).
Incremental Validity of MBPD
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As with the substance user sample, we examined whether MBPD scores explained anything
beyond negative affectivity. We conducted a series of hierarchical regressions with gender
and Negative Emotionality scores entered in the first step, MBPD scores entered in the
second step, and the external correlates of BPD entered as criterion variables. Given the
sheer number of variables in the two prison samples, we used only variables that
conceptually overlapped with Study 1 (i.e., AAB child and adult symptoms, indices of EXT,
and drug and alcohol misuse). MBPD scores were incrementally predictive of CD symptoms
(R2Δ = .009, p < .01), the ADS (R2Δ = .023, p < .01), the SDAST (R2Δ = .014, p < .01), and
a history of suicide attempts (OR = 1.18, p < .001). However, the MTSD-BPD was not
predictive of AAB symptoms (R2Δ = .001, p = .21).
Some variables—including PTSD and indices of INT—were only assessed among male or
female prisoners. We conducted similar incremental analyses because of the theoretical
relevance of such variables (although these analyses controlled for negative emotionality
only). We examined the incremental validity of MBPD scores on PTSD symptoms among
women and on BDI (as an index of INT) among men. MBPD scores were predictive of
PTSD symptoms (R2Δ = .027, p < .01) and of the BDI (R2Δ = .056, p < .01). These results
provide additional evidence of incremental validity beyond measures of negative affect.
Study 2 Discussion
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Consistent with previous evidence documenting the correlates of BPD in psychiatric and
substance user samples (Bornovalova et al, 2006; Gratz et al, 2008; Zanarini et al, 1997,
1998a, 1998b), MBPD scores were associated with externalizing behavior, internalizing
distress, substance use frequency and severity, and traumatic experiences. Associations
between MBPD scores and normal range personality traits also mirrored previous results
(Trull et al, 2003; Costa & McCrae, 1990), including measures of negative affectivity, poor
socialization, and behavioral disinhibition across a number of personality inventories. Thus,
the MBPD scale exhibited good convergent validity with relevant external correlates in the
prisoner sample. MBPD scores also predicted measures of psychopathology and
maladaptive behavior, even when controlling for negative emotionality. These results
validate the utility of the MBPD in samples at elevated risk for BPD.

General Discussion
The current study developed and tested the construct validity of a new self-report measure of
BPD, the MBPD. To restate a crucial point, the ultimate goal of this scale development
study was pragmatic, in that we aimed to develop an index of BPD traits from a measure
that is in common use (the MPQ), including in several important epidemiological
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investigations. By incorporating data from multiple large samples, spanning a diverse range
of participants, and employing criterion measures of various types, the current pair of studies
provided for a rigorous assessment of the validity of this new self-report BPD scale. In turn,
the development of this novel scale allows researchers to calculate an index of BPD and
answer questions that, for practical and financial considerations, cannot be answered in
general BPD studies – for instance, questions about the longitudinal course, heritability, or
genomic markers associated with BPD.
Construct Validity and Incremental Validity
First, our results indicated that the MBPD has strong internal consistency reliability across
all the samples in this study (average α = .81). Second, it strongly correlated with other selfreport BPD measures and moderately correlated with diagnosed BPD. The incremental
validity analyses suggest the MBPD provides valuable clinical information beyond
measuring negative emotionality, because across the study samples, the MBPD accounted
for significant variance beyond MPQ Negative Emotionality.
External Correlates of MBPD
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Consistent with previous research and our study hypotheses, results for the MBPD indicate
significant association with indices of behavioral disinhibition, including measures of
antisocial behavior, criminality, violence, substance abuse, and disinhibitory personality
traits. The MBPD scores also correlated with measures of internalizing psychopathology and
childhood and adult trauma. As a whole, then, scores on the MBPD scale behaved in a
manner consistent with how the BPD construct as indexed by DSM criteria is known to
behave; as such, the current data provide strong evidence for the construct validity of MBPD
as a measure of the larger BPD construct.
Gender Differences
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Notably, the current study also examined gender differences in the strength of associations
of MBPD with external criterion variables. Although gender differences were not observed
in the sample of community adult youth, there were gender differences within the two
samples of prisoners (and the substance user sample was too small to detect differences).
These disparate results are not surprising given the equivocality in the research literature
about the linkage between gender and BPD correlates (Golomb, Fava, Abraham, &
Rosenbaum, 1995; Grilo, 2002; Johnson et al, 2003; Zlotnick, Rothschild, & Zimmerman,
2002; Zanarini et al, 1998a). Since the studies that found gender differences in the correlates
of BPD generally used adult clinical samples, the disparity across (our) samples might stem
from differences in sample characteristics (age, SES, and prevalence of clinical disorders
including substance use problems) as well.
Despite the multiple strengths of the study, several limitations should also be acknowledged.
First, we do not claim that the MBPD scale, specifically created for the use in existing
studies that included the MPQ, would necessarily work as well as a scale constructed from
scratch using a clinical BPD group. Second, because the MTFS and prisoner studies lacked a
direct measure of BPD, we utilized correlations with relevant criterion variables to infer
validity of the MBPD scale. Third, as suggested by Dulit et al (1990), a diagnosis of BPD in
the urban drug user sample might be confounded by long-standing substance use.
Nevertheless, Dulit et al. found that even after accounting for substance abuse symptoms
that overlapped with BPD symptoms, the rate of BPD among substance abusers remained
high (67%), adding confidence that a diagnosis of BPD in such individuals is not wholly
attributable to substance misuse. Finally, the study analyses also did not examine the
discriminant validity or the test-retest reliability of the MBPD – a clear direction for followup work.
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Despite the above limitations, the current study successfully developed a new self-report
measure of BPD tendencies that demonstrated good validity across several conceptually and
clinically relevant criteria. This work provides a basis for researchers to index BPD
tendencies using items from a broadband inventory of normal personality that has been
administered in large-scale longitudinal epidemiological studies (Iacono et al., 1999;
Krueger et al., 1998; Silva, 1990; Roberts, Caspi, & Moffitt, 2001). Using the MPQ-based
BPD scale developed here, follow-up investigations can answer a number of interesting
questions. First, employing data from existing large-scale studies can be used to examine
such questions as longitudinal change in BPD levels, the influence of co-occurring
psychopathology (e.g., substance use) on temporal stability and change, and the relationship
of BPD tendencies early in life to psychological adjustment and adaptive functioning in later
years. Moreover, the current study sets the stage for novel work that draws on the unique
features in the longitudinal datasets that administer the MPQ. For instance, the MTFS
includes monozygotic and dizygotic twin and family data, as well as molecular genetic
information. The MBPD scale then will allow for quantitative genetic and molecular genetic
studies of BPD. Work of this kind is likely to contribute substantially to knowledge of the
etiology of BPD, and in turn, to methods for preventing and treating this very serious and
debilitating disorder.
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Zero-Order Correlations and Gender Differences between the MBPD and External Correlates in the Male (N =
94) and Female (N = 52) Inner-City Substance Users
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Zero-Order Correlations between the MBPD and Clinical Variables in the MTFS Male (N = 505) and Female
(N = 628) Samples
MPQ-BPD
Male

Gender Difference
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Criterion variable

Contrast Z

Nicotine Use/Dependence

.22***

.34***

−1.54

Alcohol Use/Dependence

.20***

.31***

−1.39

Drug Use/Dependence

.20***

.23***

−.37

Antisocial Behavior/

.32***

.41***

−1.22

Externalizing

.31***

.40***

−1.21

Internalizing

.18***

.29***

−1.37

Behavioral Disinhibition

*

p < .05;

NIH-PA Author Manuscript

**

p < .01;

***

p < .001.

None of the differences in the magnitude between the correlations across gender were significant.
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Table 4
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Zero-Order Correlations and Gender Differences between the MBPD and External Variables in the Male (N =
240) and Female (N = 226) Prison Inmates.
MPQ-BPD
Males

Gender-Difference

Females

Criterion Variable

Contrast Z

Conduct disorder

.18**

.42***

−2.85**

Adult antisocial behavior

.23***

.37***

−1.65

Charges before age 17

−.02

.28***

−3.30**

Age of 1st charge

−.08

−.29***

2.34**

.12

.19**

−.77

Violent behavior composite

.21**

.36***

−1.76

Survey of Alcohol and Drug Use

.21**

.25***

−.45

Social

.06

.23**

−1.87

Coping

.16*

.39***

−2.68**

Enhancement

.09

.29***

−2.23**

Alcohol dependence scale

.42***

.42***

.00

Short Drug Abuse Screening Test

.29***

.25***

.46

Criminal variety index

Drinking Motives Questionnaire

NIH-PA Author Manuscript

Mental health treatment

.36***

History of suicide attempts

.25***

Beck depression inventory

.48***

Penn State Worry scale

.48***

FEQ Total anxiety

.54***

.31***

−.70

Fear Survey Schedule

NIH-PA Author Manuscript

Total

.32***

Social fears

.32***

Agoraphobia fears

.27***

Fears of bodily injury, death, & illness

.18*

Fears of sexual & aggression scenes

.23**

Fears of harmless animals

.15

Traumatic life events - assaults

.34***

Traumatic life events - total

.27***

PTSD symptoms

.56***

NEO-FFI Five Factor Inventory
Neuroticism

.64***

Extraversion

−.35***
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MPQ-BPD
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Males
Criterion Variable

Gender-Difference

Females
Contrast Z

Openness

−.22**

Agreeableness

−.46***

Conscientiousness

−.44***

EASI Temperament Inventory
Emotionality: Distress

.55***

Emotionality: Fearfulness

.38***

Emotionality: Anger

.39***

Activity

.04

Sociability

−.20*

Impulsivity

.32***
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PANAS Positive Affect

−.39***

PANAS Negative Affect

.47***
−.57***

CPI Socialization scale
Anger expression questionnaire

.59***

Sensation Seeking Scale
Total

.08

Thrill and Adventure Seeking

−.17*

Experience Seeking

−.04

Boredom Susceptibility

.31***

Disinhibition

.26**

*

p < .05;

**

p < .01;

***

p < .001.
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Abbreviations: FEQ, Fenz-Epstein Questionnaire; PTSD, post-traumatic stress disorder; NEO-FFI, Neuroticism-Extraversion-Openness Five
Factor Inventory; EASI, Emotionality-Activity-Sociability-Impulsivity Temperament Survey; PANAS, Positive and Negative Affect Schedule;
CPI, California Psychological Inventory.
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Appendix

Final Items for the MBPD Scale (155/300 item versions)
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MPQ Scale
Stress Reaction

Item # (155/300 item versions)
125/292
18/95
149/ 270

Alienation

Control

NIH-PA Author Manuscript

Well-Being

Absorption

Unaccountably change from happy to sad.
Mood often fluctuates.
Sometimes am “on edge” all day.

78/131

Sometimes feel strong emotions without knowing why.

90/212

Sometimes over-react to minor problems.

42/ 147

Mean things often said about me.

54/238

Often betrayed by friends.

126/ 250

Often been lied to.

150/103

Often have bad luck.

86/ 41

Often act impulsively.

44/ 26

Usually make decisions very carefully.

128/ 176
Aggression

Abbreviated Item

8/82

Often not cautious enough.
Often want to hit someone when angry.

127/293

Sometimes like to hit someone.

151/ 158

Sometimes enjoy saying mean things.

74/ 170

Most mornings day seems bright.

104/ 159

Rarely feel happy.

--/76

Sometimes experience a “different state of being.”

--/ 40

My mind sometimes encompasses world.

71/ --

Often “sense” people before seeing them.

130/--

Sometimes feel presence of people not actually there.

Note: There are actually several different versions of the MPQ: the 300 item version, and the 155 item version (a 198-item version has been used at
the University of Minnesota previously as well, but this format is not used anywhere else). The 300 item version (very widely used) has both a 2and a 4-point response format (true/false for 2-point response format; definitely true, probably true, probably false, and definitely false for 4-point
response format), and the 198-item version has a 4-point response format only. The brief MPQ (155-item version) has a binary (True/False) format.
Because some labs use the 300-item version and others use the 155-item version, we created an MBPD version for each full MPQ format.
Therefore, MBPD scores can range from 19–76 when using the 300-item version of the MPQ, and from 0–19 when using the MPQ-BF. The double
dash symbol shows which items did not have an equivalent between versions.
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